Gestational exposure to unmethylated CpG oligonucleotides dysregulates placental molecular clock network and fetoplacental growth dynamics, and disrupts maternal blood pressure circadian rhythms in rats
preprint
OA: closed
Abstract
Bacterial infections and impaired mitochondrial DNA dynamics are associated with adverse pregnancy outcomes. Unmethylated cytosine-guanine dinucleotide (CpG) motifs are common in bacterial and mitochondrial DNA and act as potent immunostimulators. Here, we tested the hypothesis that exposure to CpG oligonucleotides (ODN) during pregnancy would disrupt blood pressure circadian rhythms and the placental molecular clock machinery, mediating aberrant fetoplacental growth dynamics. Rats were repeatedly treated with CpG ODN in the 3 rd trimester (gestational day, GD, 14, 16, 18) and euthanized on GD20 (near term) or with a single dose of CpG ODN and euthanized 4 hours after treatment on GD14. Hemodynamic circadian rhythms were analyzed via Lomb-Scargle periodogram analysis on 24-h raw data collected continuously via radiotelemetry. A p -value ≥ 0.05 indicates the absence of a circadian rhythm. Following the first treatment with CpG ODN, maternal systolic and diastolic blood pressure circadian rhythms were lost ( p ≥ 0.05). Blood pressure circadian rhythm was restored by GD16 and remained unaffected after the second treatment with CpG ODN ( p < 0.0001). Diastolic blood pressure circadian rhythm was again lost after the last treatment on GD18 ( p ≥ 0.05). CpG ODN increased placental expression of Per2 and Per3 and Tnfα ( p ≤ 0.05) and affected fetoplacental growth dynamics, such as reduced fetal and placental weights were disproportionately associated with increases in the number of resorptions in ODN-treated dams compared to controls. In conclusion, gestational exposure to unmethylated CpG DNA dysregulates placental molecular clock network and fetoplacental growth dynamics and disrupts blood pressure circadian rhythms.
My notes (saved in your browser only)
Citation neighborhood (no data yet)
We don't have any in-corpus citations linked to this paper yet. The paper's references may be in our DB but unresolved to ``paper_id`` (resolution happens at ingest when the cited DOI matches a row we already have). Run the cross-source citation reconcile pass to retry.
References (66)
- doi:10.3389/fimmu.2020.575197 via crossref
- doi:10.1111/aji.12355 via crossref
- doi:10.3389/fimmu.2020.01672 via crossref
- doi:10.1089/fpd.2018.2548 via crossref
- doi:10.1093/cid/cir325 via crossref
- doi:10.1016/j.ajog.2021.07.009 via crossref
- doi:10.1080/14787210.2021.1882849 via crossref
- doi:10.1002/jmv.27138 via crossref
- doi:10.1080/14767058.2017.1311318 via crossref
- doi:10.1146/annurev.immunol.20.100301.064842 via crossref
- doi:10.4049/jimmunol.1103454 via crossref
- doi:10.1038/374546a0 via crossref
- doi:10.4049/jimmunol.156.2.558 via crossref
- doi:10.1016/j.vaccine.2022.12.047 via crossref
- doi:10.1016/j.clinthera.2022.10.002 via crossref
- doi:10.1016/j.vaccine.2022.09.071 via crossref
- doi:10.3389/fimmu.2022.983621 via crossref
- doi:10.1016/j.vaccine.2022.10.030 via crossref
- doi:10.1080/21645515.2022.2136912 via crossref
- doi:10.1007/978-1-0716-0872-2_4 via crossref
- doi:10.1152/ajpregu.00324.2019 via crossref
- doi:10.1016/j.placenta.2010.06.018 via crossref
- doi:10.1530/rep-17-0619 via crossref
- doi:10.1016/j.freeradbiomed.2017.11.024 via crossref
- doi:10.1093/eurjpc/zwac020 via crossref
- doi:10.1152/ajprenal.00071.2020 via crossref
- doi:10.1080/10641955.2020.1797777 via crossref
- doi:10.1177/0961203320951274 via crossref
- doi:10.1371/journal.pgen.1009933 via crossref
- doi:10.3390/ijms23126846 via crossref
- doi:10.1073/pnas.0701466104 via crossref
- doi:10.1016/j.placenta.2012.03.008 via crossref
- doi:10.3109/19396368.2015.1069420 via crossref
- doi:10.1152/ajpheart.00834.2015 via crossref
- doi:10.1016/j.phrs.2017.04.012 via crossref
- doi:10.1161/hypertensionaha.117.10510 via crossref
- doi:10.3390/pharmaceutics14010073 via crossref
- doi:10.1038/nri3386 via crossref
- doi:10.1080/09291010600903692 via crossref
- doi:10.1076/brhm.30.2.178.1422 via crossref
- doi:10.1016/0890-6238(92)90009-i via crossref
- doi:10.1016/j.sleep.2006.11.011 via crossref
- doi:10.1016/j.archger.2008.10.003 via crossref
- doi:10.1111/j.1552-6909.2000.tb02771.x via crossref
- doi:10.1152/ajpheart.01089.2003 via crossref
- doi:10.2147/jir.s294630 via crossref
- doi:10.1177/1753495x12473751 via crossref
- doi:10.1161/hypertensionaha.122.19175 via crossref
- doi:10.1016/s0002-9378(99)70611-3 via crossref
- doi:10.1095/biolreprod.116.145946 via crossref
- doi:10.1016/j.jri.2012.12.005 via crossref
- doi:10.1152/physrev.1979.59.3.449 via crossref
- doi:10.1038/s41580-019-0179-2 via crossref
- doi:10.1530/jme-19-0153 via crossref
- doi:10.4049/jimmunol.1301982 via crossref
- doi:10.3390/ijms21249743 via crossref
- doi:10.4049/jimmunol.0900788 via crossref
- doi:10.1016/j.bbrc.2015.12.024 via crossref
- doi:10.7554/elife.59258 via crossref
- doi:10.1038/s41598-022-22507-3 via crossref
- doi:10.1038/nm.2541 via crossref
- doi:10.1038/s41590-020-00845-6 via crossref
- doi:10.1161/jaha.121.021726 via crossref
- doi:10.1038/s41598-019-42551-w via crossref
- doi:10.1016/j.jri.2012.01.008 via crossref
- doi:10.1016/j.vaccine.2005.07.105 via crossref
Source provenance
- crossref
- last seen: 2026-06-14T06:15:41.833744+00:00
- europepmc
- last seen: 2026-05-19T01:45:01.086888+00:00
- unpaywall
- last seen: 2026-07-19T06:49:21.617583+00:00